Discontinued — last reported Q2 '17
PepsiCo Long-Term Debt - Fair Value increased by 2.1% to $48.00B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $42.00B to $48.00B. Over 4 years (FY 2020 to FY 2024), Long-Term Debt - Fair Value shows a downward trend with a -5.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to book value may indicate rising interest rates or changes in credit risk, while a decrease may suggest favorable refinancing opportunities.
This represents the estimated market value of the company's long-term debt obligations if they were to be settled or tra...
Standard across large-cap pharmaceutical firms, often compared against total debt to assess interest rate sensitivity.
long_term_debt_fair_value| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.00B | $46.00B | $43.00B | $38.00B | $37.00B | $36.00B | $35.00B | $39.00B | $40.00B | $40.00B | $41.00B | $42.00B | $41.00B | $42.00B | $40.00B | $45.00B | $47.00B | $48.00B |
| QoQ Change | — | +0.0% | -6.5% | -11.6% | -2.6% | -2.7% | -2.8% | +11.4% | +2.6% | +0.0% | +2.5% | +2.4% | -2.4% | +2.4% | -4.8% | +12.5% | +4.4% | +2.1% |
| YoY Change | — | — | — | — | -19.6% | -21.7% | -18.6% | +2.6% | +8.1% | +11.1% | +17.1% | +7.7% | +2.5% | +5.0% | -2.4% | +7.1% | +14.6% | +14.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.